FDA approves new drug for multiple sclerosis
The Food and Drug Administration said Wednesday it approved a new drug from Biogen Idec to control multiple sclerosis in adults with hard-to-treat forms of the disease.
It is being reported that scientists have used stem cells to reverse the symptoms associated with multiple sclerosis.